Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy

被引:29
作者
Elshaikh, MA
Angermeier, K
Ulchaker, JC
Klein, EA
Chidel, MA
Mahoney, S
Wilkinson, DA
Reddy, CA
Ciezki, JP
机构
[1] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Radiat Oncol & Urol, Cleveland, OH 44195 USA
[3] Kaiser Permanente, Dept Urol, Cleveland, OH USA
关键词
D O I
10.1016/S0090-4295(02)02142-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To correlate anatomic, procedural, and dosimetric parameters with the rate of intermittent self-catheterization (ISC). Methods. The records of 402 patients with a median age of 69 years treated with I-125 prostate seed implantation from 1996 to 2001 were reviewed for the use of ISC. The records were examined for the preimplant factors: prostate volume, use of androgen deprivation, and prostate length. The intraprocedural factor reviewed was the number of needles used. The following postimplant information was also collected: preimplant transrectal ultrasound-generated prostate volume/postimplant computed tomography-generated prostate volume ratio, V-100, V-150, V-200, V-300, V-400, D-90, and D-100. Correlation was assessed using logistic regression analysis. Results. Forty-four patients had to use ISC (10.9%). The mean and median duration of ISC was 11.9 and 6 weeks, respectively. From univariate analysis, prostate length and prostate volume were found to be statistically significant predictors of ISC after I-125 prostate seed implantation with a P value of 0.0002 and 0.0042, respectively. With multivariate analysis, only prostate length was a statistically significant predictor of ISC use after I-125 prostate seed implantation (P = 0.0095). Conclusions. Prostate length is an important predictor of ISC after I-125 prostate seed implantation. UROLOGY 61: 152-155, 2003. (C) 2003, Elsevier Science Inc.
引用
收藏
页码:152 / 155
页数:4
相关论文
共 15 条
[1]   A comparison of complications between ultrasound-guided prostate brachytherapy and open prostate brachytherapy [J].
Benoit, RM ;
Naslund, MJ ;
Cohen, JK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :909-913
[2]  
BLASKO JC, 1991, SCAND J UROL NEPHROL, P113
[3]   Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation [J].
Crook, J ;
McLean, M ;
Catton, C ;
Yeung, I ;
Tsihlias, J ;
Pintilie, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02) :453-460
[4]   Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Blank, K ;
Broderick, GA ;
Tomaszewski, JE ;
Renshaw, AA ;
Kaplan, I ;
Beard, CJ ;
Wein, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :969-974
[5]   TREATMENT-RELATED SYMPTOMS DURING THE 1ST YEAR FOLLOWING TRANSPERINEAL I-125 PROSTATE IMPLANTATION [J].
KLEINBERG, L ;
WALLNER, K ;
ROY, J ;
ZELEFSKY, M ;
ARTERBERY, VE ;
FUKS, Z ;
HARRISON, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (04) :985-990
[6]   Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy [J].
Lee, N ;
Wuu, CS ;
Brody, R ;
Laguna, JL ;
Katz, AE ;
Bagiella, E ;
Ennis, RD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (05) :1457-1460
[7]   Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study [J].
Locke, J ;
Ellis, W ;
Wallner, K ;
Cavanagh, W ;
Blasko, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :712-719
[8]   The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis [J].
Nag, S ;
Bice, W ;
DeWyngaery, K ;
Prestidge, B ;
Stock, R ;
Yu, Y .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (01) :221-230
[9]   Intraoperative planning and evaluation of permanent prostate brachytherapy: Report of the American Brachytherapy Society [J].
Nag, S ;
Ciezki, JP ;
Cormack, R ;
Doggett, S ;
DeWyngaert, K ;
Edmundson, GK ;
Stock, RG ;
Stone, NN ;
Yu, Y ;
Zelefsky, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (05) :1422-1430
[10]   American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer [J].
Nag, S ;
Beyer, D ;
Friedland, J ;
Grimm, P ;
Nath, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (04) :789-799